Q3 Performance and Segmental Breakdown
Cyient DLM ne Q3 FY26 ke liye ₹303.30 crore ka revenue report kiya, jo ki expectations se kam tha, kyunki pichhle saal ke comparable quarter mein ek bada order khatam ho gaya tha. Segment contributions mein mixed performance dikhi. Aerospace and defence, medical technology, aur industrials ne respectively 37%, 8%, 16%, aur 30% ka yogdan diya. Jabki Aerospace aur Industrials mein saal-dar-saal 14.8% aur 57.6% ki growth dekhi gayi, Defence aur Medical Technology mein tezi se 88.1% aur 39.3% ki kami aayi. Margin-accretive cables segment ne strong growth dikhayi, 36.6% year-on-year up. Iske vipreet, PCBA aur box-build segments ka contribution kam ho kar respectively 51.0% aur 25.8% ho gaya. Ye fluctuations Cyient DLM ke diverse service offerings aur unke alag-alag market dynamics ko highlight karte hain.
Analyst's Forward Outlook and Growth Projections
Q3 revenue miss ke bawajood, analysts ko Q4 FY26 se revenues mein gradual recovery ki ummeed hai. Ye optimism ek mazboot order book aur healthy book-to-bill ratio par आधारित hai. Management deferred shipments execute karne par bhi focus kar raha hai, jisse near-term performance boost hone ki ummeed hai. Fiscal year 2027, fiscal year 2026 se materially stronger hone ka anuman hai. Analysts forecast karte hain ki Cyient DLM medium term mein consistent growth dega. Expected revenue, EBITDA, aur PAT FY25 aur FY28 ke beech respectively 10.6%, 13.7%, aur 19.1% ki compound annual growth rates (CAGR) se grow karenge. Ye sustained growth trajectory positive outlook ka key factor hai.
Margin Expansion and Valuation
Margin improvements bhi analyst report mein ek central theme hain. Margins double digits mein rehne aur higher trend karne ki ummeed hai. Iska reason scaling volumes se operating leverage, structurally healthier product and industry mix, aur Build-to-Service (B2S) programs se badhta hua contribution hai. Ye factors profitability ko enhance karne ke liye expected hain. Stock ko FY28 estimated Earnings Per Share (EPS) par 26 times ke Price-to-Earnings (P/E) multiple par value karte hue, analysts ne apna 'Buy' rating maintain kiya hai. Revised target price ₹416 set kiya gaya hai, jo ki improving earnings visibility aur strengthening margin profile ko reflect karta hai. Ye target price current levels se significant upside potential suggest karta hai.